The latest news from academia, regulators
research labs and other things of interest
Posted: Jul 18, 2017
Stimuli-responsive 'cluster bombs' for tumor therapy
(Nanowerk News) Researchers have designed a a pH-responsive size-changeable “Cluster Bomb”
based on mesoporous silica nanoparticle (MSN, ∼ 50nm) and peptide tLyP-1-modified tungsten disulfide quantum dots (WS2-HP) programmed tumor therapy.
By harnessing the rapid acid-responsiveness of benzoic-imine bond, the team from Wuhan University obtained a promising antitumor nanomedicine DOX@WS2-HP that is stable in systemic circulation and can break into electropositive DOX@MSN-NH2 and small-sized WS2-HP immediately after tumor accumulation.
Limited tumor penetration is the main hindrance for nanomedicines in solid tumor treatment, attributed to its disorganized vasculature, increased interstitial fluid pressure, and dense extracellular matrix in the solid tumor microenvironment.
Nanomedicines usually infiltrated into no more than one or two cell layers away from the blood vessels and failed to penetrate the tumor parenchyma throughout.
Interestingly, the team's decorated tLyP-1 peptide can not only homing to 4T1 tumors but also facilitate the tumor penetration of small-sized WS2-HP via a NRP-1dependent CendR pathway.
Unlike previous conventional tumor-penetrating strategies, the researchers exploited a hybrid strategy that integrated size control and functional peptide modification to enhance the tumor penetration of WS2-HP.
The deep-penetrated WS2-HP could exert predominant
capability of light-to-heat conversion for photothermal therapy among the interior malignant cells which are distant from blood vessels.
Meanwhile, electropositive DOX@MSN-NH2 can be readily endocytosed by the exterior tumor cells near the blood vessels and exhibit outstanding chemotherapeutic efficiency in supplement for photothermal therapy.
"Looking forward, in consideration of heterogeneity of tumor cells, this “Cluster Bomb” strategy that using different therapeutic modalities to treat the tumor cells in different depths may provide a good idea for tailored multimode therapy," the authors conclude their report.